How (re)insurers deal with weight-loss drugs in APAC
    
        
            
                
            Source: Asia Insurance Review | Feb 2025
         
     
    
    
    
    
    
    
    
    Insurers in APAC are no doubt closely monitoring the evolving landscape of development and usage of weight loss drugs. Despite the current high costs and unknown long-term factors, they can be a valuable tool in tackling the projected increase of obesity in the region.  
 
 
    
    
    
    
    
	
        
		
        
            
                
				
					
						Archived articles are available to Magazine subscribers only.
						
						
						
						
						
					 
					
						For Full Access to
                        the magazine 
SUBSCRIBE here.